422 related articles for article (PubMed ID: 29517942)
1. Effect of α-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy.
Agathos E; Tentolouris A; Eleftheriadou I; Katsaouni P; Nemtzas I; Petrou A; Papanikolaou C; Tentolouris N
J Int Med Res; 2018 May; 46(5):1779-1790. PubMed ID: 29517942
[TBL] [Abstract][Full Text] [Related]
2. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
Ziegler D; Hanefeld M; Ruhnau KJ; Meissner HP; Lobisch M; Schütte K; Gries FA
Diabetologia; 1995 Dec; 38(12):1425-33. PubMed ID: 8786016
[TBL] [Abstract][Full Text] [Related]
3. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
[TBL] [Abstract][Full Text] [Related]
4. The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy.
Haak ES; Usadel KH; Kohleisen M; Yilmaz A; Kusterer K; Haak T
Microvasc Res; 1999 Jul; 58(1):28-34. PubMed ID: 10388600
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of response to alpha-lipoic acid ± palmitoiletanolamide treatment in patients with diabetes and symptoms of peripheral neuropathy.
Pieralice S; Vari R; Minutolo A; Maurizi AR; Fioriti E; Napoli N; Pozzilli P; Manfrini S; Maddaloni E
Endocrine; 2019 Nov; 66(2):178-184. PubMed ID: 30949911
[TBL] [Abstract][Full Text] [Related]
6. Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients.
Ruessmann HJ;
J Diabetes Complications; 2009; 23(3):174-7. PubMed ID: 18403218
[TBL] [Abstract][Full Text] [Related]
7. The effect of alpha-lipoic acid on symptoms and skin blood flow in diabetic neuropathy.
Jin HY; Joung SJ; Park JH; Baek HS; Park TS
Diabet Med; 2007 Sep; 24(9):1034-8. PubMed ID: 17490418
[TBL] [Abstract][Full Text] [Related]
8. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.
Bouhassira D; Wilhelm S; Schacht A; Perrot S; Kosek E; Cruccu G; Freynhagen R; Tesfaye S; Lledó A; Choy E; Marchettini P; Micó JA; Spaeth M; Skljarevski V; Tölle T
Pain; 2014 Oct; 155(10):2171-9. PubMed ID: 25168665
[TBL] [Abstract][Full Text] [Related]
9. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.
Ziegler D; Gries FA
Diabetes; 1997 Sep; 46 Suppl 2():S62-6. PubMed ID: 9285502
[TBL] [Abstract][Full Text] [Related]
10. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
Ziegler D; Reljanovic M; Mehnert H; Gries FA
Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
[TBL] [Abstract][Full Text] [Related]
11. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.
Ziegler D; Nowak H; Kempler P; Vargha P; Low PA
Diabet Med; 2004 Feb; 21(2):114-21. PubMed ID: 14984445
[TBL] [Abstract][Full Text] [Related]
12. Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on symptoms of diabetic peripheral neuropathy.
Han Y; Wang M; Shen J; Zhang Z; Zhao M; Huang J; Chen Y; Chen Z; Hu Y; Wang Y
Minerva Endocrinol; 2018 Mar; 43(1):11-18. PubMed ID: 27901334
[TBL] [Abstract][Full Text] [Related]
13. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).
Tankova T; Koev D; Dakovska L
Rom J Intern Med; 2004; 42(2):457-64. PubMed ID: 15529636
[TBL] [Abstract][Full Text] [Related]
14. Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study.
El-Nahas MR; Elkannishy G; Abdelhafez H; Elkhamisy ET; El-Sehrawy AA
Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1531-1534. PubMed ID: 32370731
[TBL] [Abstract][Full Text] [Related]
15. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
Ziegler D
Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
[TBL] [Abstract][Full Text] [Related]
16. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy.
Negrişanu G; Roşu M; Bolte B; Lefter D; Dabelea D
Rom J Intern Med; 1999; 37(3):297-306. PubMed ID: 15532308
[TBL] [Abstract][Full Text] [Related]
17. The role of alpha-lipoic acid in diabetic polyneuropathy treatment.
Bureković A; Terzić M; Alajbegović S; Vukojević Z; Hadzić N
Bosn J Basic Med Sci; 2008 Nov; 8(4):341-5. PubMed ID: 19125705
[TBL] [Abstract][Full Text] [Related]
18. Alpha lipoic acid and glycaemic control in diabetic neuropathies at type 2 diabetes treatment.
Ibrahimpasic K
Med Arch; 2013; 67(1):7-9. PubMed ID: 23678828
[TBL] [Abstract][Full Text] [Related]
19. α-Lipoic acid, diabetic neuropathy, and Nathan's prophecy.
Papanas N; Maltezos E
Angiology; 2012 Feb; 63(2):81-3. PubMed ID: 22253286
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
Hahm JR; Kim BJ; Kim KW
J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
